Live Quote · NASDAQABCLHealthcare· Biotechnology

AbCellera Biologics Inc.

$9.69▼ 7.45%($-0.78)
MKT CAP $3.16BNEXT EARNINGS Feb 23, 2027
50%
Bullish
TickerSpark Score
63/100
▌ Mixed
40
Valuation
40
Profitability
90
Growth
84
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABCL research report →

Analyst Price Target
$18.20+87.8% vs. today

Range $9 – $30

Analyst RatingBuy
12 Buy1 Hold0 Sell

Price Chart

+190.03% · this period
$14.82$8.80$2.78Nov 19May 22Nov 19
52-Week Range57% of range
Low
$2.75
Current
$9.69
High
$15.02